AI Insight
Hundreds of scientific papers in cancer and cell aging research may contain erroneous results due to researchers using antibodies that targeted the wrong protein. The mix-up stems from confusion over protein names, leading scientists to inadvertently study a different molecule than intended. This nomenclature error has potentially compromised the validity of findings across multiple studies that relied on these mislabeled antibodies.
Why it matters
This discovery highlights a systemic problem in scientific research where inadequate standardization of protein naming can lead to widespread experimental errors. The affected studies may need to be re-evaluated or retracted, and ongoing research in cancer and aging fields should verify they are using correctly labeled reagents.
Cancer and cell aging studies may have relied on antibodies to incorrect molecule
Source: Protein name confusion created antibody mix-up affecting hundreds of papers